Abstract
The combination of basal insulin (BI) and GLP-1 receptor agonists (GLP-1RAs) is a rational and effective therapy for patients with uncontrolled type 2 diabetes (T2D). We compared the effectiveness of fixed and flexible BI/GLP-1RA combinations using routinely accumulated clinical data. This was a retrospective, multicentre, real-world study concerning T2D patients initiating a fixed or flexible BI/GLP-1RA combination (NCT03959865). The primary endpoint was change in HbA1c. Secondary endpoints were changes in body weight, fasting plasma glucose (FPG) and systolic blood pressure (SBP). Confounding was addressed by propensity score matching (PSM) or multivariable adjustment (MVA). A total of 609 patients were included in the study, 131 in the fixed group and 478 in the flexible group. The two groups differed in terms of diabetes duration, body weight and concomitant medications. After 5.7 months, observed HbA1c reductions were 0.6% and 0.8%, and body weight reductions were 2.8 kg and 1.2 kg in the flexible and fixed groups, respectively. Following PSM, HbA1c declined similarly in the two groups, whereas reduction in body weight was significantly in favour of the flexible combination. Findings were robust in sensitivity analyses, wi...Continue Reading
References
May 28, 2010·Diabetes Research and Clinical Practice·Wenying YangPhilip D Home
Feb 11, 2012·Endocrine Reviews·John R Ussher, Daniel J Drucker
Oct 9, 2012·Diabetes Care·Bernard ZinmanUNKNOWN NN1250-3579 (BEGIN Once Long) Trial Investigators
Oct 16, 2012·Diabetes, Obesity & Metabolism·R BalenaA H Barnett
Sep 16, 2014·Lancet·Conrad EngRavi Retnakaran
Aug 8, 2015·Cardiovascular Diabetology·Sanjoy K PaulKamlesh Khunti
Jan 9, 2016·Diabetes, Obesity & Metabolism·K KhuntiS K Paul
Jan 17, 2016·Diabetes & Metabolism·B Cariou
Jan 1, 2015·International Journal of Statistics in Medical Research·Yang Liu, Anindya De
Oct 8, 2016·Diabetes, Obesity & Metabolism·Sonal SinghRattan Juneja
Oct 8, 2016·Diabetes, Obesity & Metabolism·Mirna S Abd El AzizMichael A Nauck
Dec 17, 2016·Diabetes, Obesity & Metabolism·Zin Z HtikeMelanie J Davies
Jan 21, 2017·Diabetes, Obesity & Metabolism·Linong JiSatish K Garg
Nov 10, 2017·Diabetes, Obesity & Metabolism·Liyue TongLuigi F Meneghini
Dec 10, 2017·The Lancet. Diabetes & Endocrinology·M Angelyn BethelUNKNOWN EXSCEL Study Group
Jan 25, 2018·Diabetes, Obesity & Metabolism·Sudesna ChatterjeeKamlesh Khunti
Mar 9, 2018·Diabetes, Obesity & Metabolism·Gian Paolo FadiniUNKNOWN DARWIN-T2D network
May 8, 2018·Diabetes, Obesity & Metabolism·Maria Ida MaiorinoDario Giugliano
Aug 15, 2018·Diabetes Care·Julio RosenstockGeremia B Bolli
Aug 24, 2018·Diabetes, Obesity & Metabolism·Gian Paolo FadiniUNKNOWN DARWIN-T2D Network
Oct 3, 2018·Diabetes/metabolism Research and Reviews·Marco CastellanaFrancesco Giorgino
Oct 7, 2018·Diabetes Care·Melanie J DaviesJohn B Buse
Dec 24, 2018·Diabetes, Obesity & Metabolism·Gian Paolo FadiniUNKNOWN DARWIN-T2D Network
Jan 6, 2019·Advances in Therapy·Leigh PerreaultEric Johnson
Jan 22, 2019·Lancet·Hertzel C GersteinRury R Holman
Apr 16, 2019·Diabetes, Obesity & Metabolism·Gian Paolo FadiniUNKNOWN DARWIN-T2D network
Citations
Jan 17, 2020·Diabetes, Obesity & Metabolism·Veronica SciannameoUNKNOWN DARWIN-T2D study
Apr 18, 2020·The Journal of Clinical Endocrinology and Metabolism·Mario Luca MorieriGian Paolo Fadini
May 27, 2020·Diabetes/metabolism Research and Reviews·Mario Luca MorieriUNKNOWN DARWIN-FUP network
Nov 2, 2019·Acta Diabetologica·Gian Paolo FadiniAngelo Avogaro
Oct 27, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Luciano ZenariAnnunziata Lapolla
Feb 8, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Gian Paolo FadiniAgostino Consoli
Feb 7, 2021·Diabetes Research and Clinical Practice·Benedetta Maria BonoraGian Paolo Fadini
Nov 19, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Mario Luca MorieriGian Paolo Fadini